Feedback / Questions
VTx-002 - VectorY
https://www.businesswire.com/news/home/20260108064177/en/VectorY-Therapeutics-Receives-FDA-Fast-Track-Designation-for-VTx-002-a-First-in-Class-Vectorized-Antibody-Targeting-Underlying-Disease-Biology-in-ALS
Jan 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next